Results 151 to 160 of about 1,271,889 (407)
Anemia, 2018 Background. Anemia is a public health problem especially among pregnant women. This study aimed to investigate the prevalence of anemia and iron deficiency among pregnant women and its association with pregnancy outcome in Hebron Governorate in southern ...
Mahmoud A. Srour +4 more
doaj +1 more source
OBSERVATIONS ON THE EFFECT OF AN ANIMAL PROTEIN FACTOR CONCENTRATE ON PERSONS WITH THE MACROCYTIC ANEMIA OF PERNICIOUS ANEMIA, OF NUTRITIONAL MACROCYTIC ANEMIA AND OF SPRUE, AND ON PERSONS WITH NUTRITIONAL GLOSSITIS [PDF]
, 1949 Tom D. Spies +6 more
openalex +1 more source
American Journal of Hematology, EarlyView.ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo +23 more
wiley +1 more source
Klippel–Trenaunay syndrome associated with chronic myeloid leukemia
Hematology, Transfusion and Cell Therapy, 2020 C. Coskun, T. Aksu, F. Gumruk, S. Unal
doaj +1 more source
Iron Deficiency Anemia: An Unexpected Cause of an Acute Occipital Lobe Stroke in an Otherwise Healthy Young Woman [PDF]
, 2020 A 29-year-old caucasian woman who presented to the hospital with an acute onset of right eye visual disturbance and headache was found to have an acute left occipital lobe infarction.
Nace, Travis C +3 more
core +1 more source
QUANTITATIVE ASPECTS OF IRON DEFICIENCY IN HYPOCHROMIC ANEMIA [PDF]
, 1932 Clark W. Heath +2 more
openalex +1 more source
American Journal of Hematology, EarlyView.Idiopathic Multicentric Castleman Disease. ABSTRACT Idiopathic multicentric Castleman disease (iMCD) is a rare cytokine‐driven disorder characterized by systemic inflammation, organ dysfunction, and altered lymph node microscopic architecture. Over the past decade, diagnostic criteria have evolved significantly, integrating clinical, histopathological,
FNU Alnoor +11 more
wiley +1 more source
BLOOD VOLUME PRECEDING AND FOLLOWING SPLENECTOMY IN HEMOLYTIC ICTERUS AND SPLENIC ANEMIA 1 [PDF]
, 1929 Herbert Z. Giffin +2 more
openalex +1 more source
The Virginia Sickle Cell Anemia Awareness Program: Education, Screening, and Counseling [PDF]
, 1977 In 1968, a program of screening for sickle trait carriers was begun as part of the work of the Hematology Division, Department of Medicine, at the Medical College of Virginia.
Cooper, Florence N., Scott, Robert B.
core +1 more source
American Journal of Hematology, EarlyView.ABSTRACT Inappropriate complement activation is a key driver of hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA). Treatment with narsoplimab, an inhibitor of MASP‐2, the effector enzyme of the lectin pathway, resulted in a response rate of 61% in a Phase 2 clinical trial in adults with TA‐TMA.
Michelle L. Schoettler +6 more
wiley +1 more source